Volume 34, 16 May 2003 05/2003
 
  SPOT ON
 

CONVINCE Study: Early Stop for Commercial Reasons Unethical

 
  NEW ON THE MARKET
 

Cox-2 Inhibitor Valdecoxib (BEXTRA)
5-Alpha-Reductase Inhibitor Dutasteride (AVODART) in Benign Prostatic Hyperplasia
Chronic Hepatitis B: Adefovir (HEPSERA)
Miglustat (ZAVESCA) as a Remedy for GAUCHER Disease

 
  REVIEW
 

Treatment of Atopic Dermatitis (II): Further Therapeutic Interventions

 
  a-t READERS' QUESTIONS AND COMMENTS
 

OMACOR After Myocardial Infarction?
Hip Protectors: Importance of Structured Education Questioned

 
  IN BRIEF
 

Menopausal Hormone Replacement Without Effect on Quality of Life

 
  CURRENT ADR NETWORK REPORT
 

Slow-Onset Myopathy Due to Statins
AZUMETOP RETARD Tablets Indigestible

 
  SIDE EFFECTS

Fatalities After Hexavalent Vaccines (HEXAVAC, INFANRIX HEXA)
Homonal Contraceptives and Cervical Cancer
Telithromycin (KETEK): Exacerbation of Myasthenia Gravis

 
© arznei-telegramm 05/2003